Literature DB >> 30131321

Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis-ulcerative colitis.

Li-Zsa Tan1, Claire R Reilly1, Lana C Steward-Harrison1, Fariha Balouch1, Richard Muir2, Peter J Lewindon1,3.   

Abstract

Entities:  

Keywords:  primary sclerosing cholangitis; ulcerative colitis; vancomycin

Mesh：

Substances：

Year:  2018        PMID： 30131321     DOI： 10.1136/gutjnl-2018-316599

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  3 in total

Review 1.  Does oral vancomycin use necessitate therapeutic drug monitoring?

Authors:  Nevio Cimolai
Journal:  Infection       Date:  2019-11-11       Impact factor: 3.553

Review 2.  The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts.

Authors:  Timur Liwinski; Melina Heinemann; Christoph Schramm
Journal:  Semin Immunopathol       Date:  2022-05-10       Impact factor: 11.759

Review 3.  Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.

Authors:  Ayesha Shah; Graeme A Macdonald; Mark Morrison; Gerald Holtmann
Journal:  Am J Gastroenterol       Date:  2020-06       Impact factor: 12.045
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.